Effect of inhaled interferon-β1a on SARS-CoV-2 diversity and evolution

By afschroeder • May 19, 2026

Edelstein GE, Sass TN, Deo R, Glover OT, Boucau J, Jaganathan P, Chew KW, Giganti MJ, Hughes MD, Moser C, Javan AC, Fletcher CV, McCarthy C, Wohl DA, Daar ES, Eron JJ, Currier JS, Singh U, Smith DM, Fischer W, Barczak AK, Choudhary MC, Li JZ; ACTIV-2/A5401 Study Team. Effect of inhaled interferon-β1a on SARS-CoV-2 diversity and evolution. Microbiol Spectr. 2026 May 18:e0054126. doi: 10.1128/spectrum.00541-26. Epub ahead of print. PMID: 42148571.

Tags: antiviral agents, Infectious Diseases, interferons, Publications, SARS-CoV-2, SARS-CoV-2 evolution, viral diversity

Assessing mpox knowledge and sexual behaviours within high-risk populations in the Democratic Republic of the Congo

Lemaille C, Halbrook M, Merritt S, Anta Y, Lunyanga L, Mukadi PK, Hasivirwe Vakaniaki E, Kalonji T, Kenye M, Kacita C, Linsuke S, Bogoch II,[...]

β-Glucan chitosan particle provides cross-protection against multi-drug-resistant Candida auris

Singh S, Barbarino A, Youssef EG, Das Gupta K, Nabeela S, Gebremariam T, Alkhazraji S, Uppuluri P, Ostroff G, Ibrahim AS. β-Glucan chitosan particle provides[...]

Dropout from the pentavalent vaccine series among children aged 12-23 months in the Central African Republic: prevalence, associated factors, and caregiver-reported barriers

Ishoso DK, Fandema E, Hoff NA, Nkamba DM, Merritt S, Halbrook M, de Dieu Longo J, Mafuta Musalu E, Kasonga Ngindu JB, Bangelesa F, Stahley[...]